The COVID-19 pandemic has significantly affected healthcare markets globally. To assess this impact in the APAC region, DRG has conducted interviews with stakeholders from prominent APAC facilities to investigate how inventory management strategies, communication with suppliers, and future purchasing processes have changed in response to COVID-19.
The webinar Impact of COVID-19 on Hospital Procurement and Supply in the APAC Region includes
- A 30 minute presentation of the methodology and results of DRG's MedTech market forecasts, highlighting COVID-19's impact on APAC markets
- An overview of results from interviews with stakeholders from prominent APAC facilities, providing insights into the impact of COVID-19 on inventory management strategies, communication with suppliers, and possible changes to future purchasing decisions
Art Butcher is Executive Vice President and President for Boston Scientific in the Asia Pacific region, a role he has held since February 2020. Currently based in Singapore, Art is responsible for the overseeing the continued growth of our business across Asia Pacific in line with our company values. He is a member of the Boston Scientific global executive committee.
Art has been with Boston Scientific for over 20 years. Prior to his current role, Art was President, Endoscopy with global responsibility for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions. He was previously Vice President and General Manager, Endoscopy in Japan.
Art has held a variety of marketing and strategic planning management positions within the Endoscopy, Urology and Pelvic Health businesses, including Vice President of Global Marketing (Endoscopy) and Vice President of New Business Development and Strategic Planning (Urology and Women’s Health). He joined Boston Scientific in 1997 as a sales representative in the Urology business.
Art holds a BA in International Relations from the University of Pennsylvania and an MBA from Columbia University.
Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.
Probir has been with Terumo Corporation since 2012 and is currently responsible for overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long-term strategy of Terumo in Asia Pacific.
Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI).
Probir also has over a decade’s teaching experience, specifically around strategy, leadership development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.
Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.
Effie Wu is the Supply Chain Lead for the Surgery Business, Ethicon in Johnson & Johnson Medical Device, Asia Pacific, where she leads the End-to-End Supply Chain efforts to bring market and patients the leading surgical solutions across the region.
Effie has been with Johnson & Johnson since the beginning of her career and has held diverse positions with increasing leadership responsibilities in Consumer and Medical Device across multiple functions and geographies. Before her current role in Medical Device, Effie also had extensive experience across End-to-End Supply Chain in Consumer sector, including leading the Asia Pacific Supply Chain for Baby Franchise, being the Regional Procurement Lead for Packaging, leading External Manufacturing in China, Japan, North Asia as well as various other roles in M&A, Process Excellence and Planning.
Effie holds a B.A. degree in Economics from Fudan University, China and an MBA from BI Norwegian Business School Oslo, Norway. Effie is also a certified LEAN Black Belt.
Andrew Lee is the Vice President of MedTech at Decision Resources Group. He oversees the MedTech product lines at DRG, which include the commercial targeting, brand tracking and insight report solutions. With 9+ years of experience, Andrew has had the privilege of leading multiple global teams within DRG delivering high-value insights and analytics to the medical device and life sciences industry. He plays an active role in creating and launching new solutions which encompass expanding geographic coverage and acquiring & integrating new data channels and companies.
Andrew holds Honors Bachelor of Science and Masters degrees from the University of Toronto.
Sana Siddiqui Syed is a Principal with DRG Consulting. Leveraging her educational background in life science and business, combined with extensive market research and consulting experience, Sana delivers strategic insights to leading healthcare and medical device companies.
Since joining DRG in 2006, Sana has written and supervised several syndicated reports and has led numerous custom engagements focusing extensively on the medical device industry. Her project experience includes industry-based market sizing reports, physician and stakeholder interviews and surveys, and patient studies that have provided insights for market landscape analyses and forecasting, market opportunity assessments, customer segmentation, product development and adoption studies, product attribute and tradeoff analyses, and competitive analyses. She also has extensive global research experience, leading project engagements for US, Canada, Europe, Latin America, Middle East, and several Asia-Pacific countries.
Sana holds an Honors Bachelor of Science degree from McMaster University, with a major in biochemistry and biomedical sciences, and a Masters in Business Administration degree from Wilfrid Laurier University.